A Multi-level Mother-daughter Physical Activity Intervention for Pre- Adolescent Latinas
San Diego State University · with National Cancer Institute (NCI) · NCT07088406
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 8–65 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 432
- US sites recruiting
- 1
- Study start
- August 21, 2025
- Record last updated
- October 2, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this Cluster Randomized Control Trial (RCT) is to learn if the mother-daughter intervention titled "Conmigo" can increase Latina preadolescents' physical activity (PA). The main objectives of the study are:
- To test the effectiveness of Conmigo on daughters' Moderate-to-Vigorous level PA (MVPA) over time
- To evaluate individual (e.g. mothers' MVPA) and family level (e.g. mother-daughter communication) mechanisms of change and their bidirectional effects
Researchers will compare the 10-week physical activity promotion intervention to a 10-week parallel intervention with emphasis on another health behavior (dietary intake) to see if there are differences in MVPA levels. We will enroll 216 Latina mother-daughter pairs at 18 elementary schools; each school will randomly receive the PA intervention or the control group program.
Mothers and daughters will attend 10 weekly sessions (2 hours each) at their elementary school, led by YMCA staff. Informed by social cognitive theory and family systems theory, the PA intervention sessions target family-level correlates of physical activity such as PA promotion parenting strategies (monitoring, role-modeling, etc.) and mother-daughter communication. Participants in the intervention group engage in weekly PA during sessions, discuss different topics each week, and set goals and receive PA homework during the week.
The investigators hypothesize that daughters participating in Conmigo will have higher minutes of device-assessed MVPA at M2 (post program), M3 (6 months post program), and M4 (12-months post program) compared to girls in the control condition.
Being studied: Physical Activity Promotion; Healthy Eating
Conditions: Physical Activity; Family Communication; Parenting Behavior
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria (DAUGHTER):
- Self-identifying as Latina
- aged 8-11
- not currently meeting CDC's 2018 PA guidelines (60 min MVPA/day)
- attends an elementary school enrolled in the study
- speaks English or Spanish
Inclusion Criteria (MOTHER):
- Self-identifying as Latina
- primary female caregiver (living with her ≥4 days/week) of the daughter
- speaks English or Spanish
- both Mother \& Daughter can attend weekly program activities for 10 weeks, and intend to stay in the area for the study's duration.
Exclusion criteria
- either Mother or Daughter has a health condition that precludes them from doing PA
- cognitive impairment affecting participation,
- inability for mother to provide informed consent or daughter to provide assent in English or Spanish
Recruiting US locations
San Diego State University
San Diego, CA 92123
Site contact: Elva Arredondo · (619) 594-3481 · earredon@sdsu.edu
Study contacts (from the official record)
- Elva Arredondo, PhD · (619) 594-3481 · earredon@sdsu.edu
- Jennifer Schneider, MPH, MA · jlbeckner@sdsu.edu
Similar studies in California
All healthy volunteers studies in California →- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Investigate the Relative Bioavailability and Safety of Different Oral Formulations of Elecoglipron in Healthy Participants
AstraZeneca
- Location
- Glendale, CA + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Phase I Study to Investigate the Pharmacokinetics and Safety of Capivasertib in Participants With Moderate Hepatic Impairment
AstraZeneca
- Location
- Rialto, CA + 1 other US site
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
Pfizer
- Location
- Lake Forest, CA + 3 other US sites
- Eligibility basics
- Ages 18–80
- RecruitingHealthy volunteersPhase 1Overnight stay mentioned
Phase 1 Study of SBS-147 in Healthy Adults
Sparian Biosciences, Inc
- Location
- Cypress, CA
- Eligibility basics
- Ages 18–55